Abstract
Surgical treatment of functional mitral regurgitation (MR) is usually based on the correction of both annular dilation and leaflet disease to minimize the risk of recurrence of MR at follow-up. This combined approach may also represent an interesting strategy during transcatheter mitral valve repair systems. We report a successful case of combined Cardioband (Edwards Lifesciences, Irvine, California) and MitraClip (Abbott, Santa Clara, California) implantation for the treatment of functional MR, with good acute and medium-term clinical and echocardiographic outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 1088.e1-1088.e2 |
Journal | Canadian Journal of Cardiology |
Volume | 34 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2018 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine